KOL Spotlight Interviews is a segment where we interview experts from various fields on their expertise and insights that help shape the diagnostic and pharmaceutical industries. This month, we had the pleasure of speaking to Dr. Balazs Halmos, Professor of Medicine, Chief, Thoracic/Head & Neck Oncology, Montefiore Medical Center/Albert Einstein College of Medicine. In this interview, Dr. Halmos shared his experience as an oncologist during the COVID-19 pandemic, particularly with hematological malignancies, or blood cancers.
COVID-19
3 Articles
As the Delta variant spreads across the world, many vaccinated individuals are worried about the possibility of a breakthrough infection. The term “breakthrough infection” refers to the development of a COVID-19 infection despite an individual being vaccinated against the virus. With many Americans still reluctant to vaccination, and with mask mandates lifted in most states, the highly contagious Delta virus has contributed to spikes in COVID-19 cases across the nation this summer ’21.
SARS-CoV-2, commonly known as the coronavirus disease 2019 (COVID-19) poses an unprecedented public health crisis. While scientists and clinicians worldwide are still working to understand the virus, recent studies show possible onset of autoimmune diseases following COVID-19 infection.